Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Dpco

Recent Highlights

National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30%

National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30%

.
Price control, ad-hoc regulatory changes and new policies may hamper pharma sector growth: Pfizer

Price control, ad-hoc regulatory changes and new policies may hamper pharma sector growth: Pfizer

.
NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%

NPPA sets deadline to lower prices of syringes and needles; manufacturers volunteer, set trade margin at 75%

.
Medical stent regulation row: Govt's move to prohibit companies from withdrawing stents is wrong

Medical stent regulation row: Govt's move to prohibit companies from withdrawing stents is wrong

.

All Stories for Dpco

All (6)
  • Prices of 56 drugs to come down; NPPA fixes ceiling rates

    Prices of 56 drugs to come down; NPPA fixes ceiling rates

    • .

    Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism.

  • De-controlling drug prices: SC refuses to interfere in Centre's decision

    De-controlling drug prices: SC refuses to interfere in Centre's decision

    Fp Archives • .

    The Supreme Court today refused to interfere with the Centre's decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation.

  • Home
  • dpco

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV